Fri, Dec 26, 2014, 12:18 AM EST - U.S. Markets open in 9 hrs 12 mins

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Jan 15, 2013 12:24 PM Flag

    Funds adding to their positions

    There is no pipeline news untill Mid Summer P2b VMAT2

    So we have a buyer slowly pushing the price up to establish a new or bigger position in NBIX

    A good thing for retail longs

    frogs

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • frogs,

      The same thing happened last January when the stock price got up to $9.98, but the rest of the year sucked. Did you see the 8K relating to compensation they filed on 14 Jan. I find it egregious. Gorman gets a bonus of $220K, four other "chiefs" get bonuses ranging from $109K to $151K. Gormans base salary will be $541K, the four other "chiefs" base salaries range from $321K to $445K. Gorman was granted 175K options, the others were granted 75K to 86K. The pigs were definitely at the trough. By every measure IMO it was a terrible year. VMAT compromised PII trial. Urocortin 2 shelved. No new compounds came out of the lab when Gorman on at least two occasions said there would be compounds coming out. Stock price was flat to down for the year and shareholders were diluted. There is more but you get the picture.

      Ochs

 
NBIX
21.33+0.09(+0.42%)Dec 24 12:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST